Ionis Pharmaceuticals, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Ionis Pharmaceuticals, Inc. (IONS) had Operating Lease, Weighted Average Discount Rate, Percent of 7.00% as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-26
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 7.00%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.90%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.90%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.90%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 7.00% 10-K · filed 2026-02-26 |
| 2024-12-31 | 6.90% 10-K · filed 2025-02-19 |
| 2023-12-31 | 6.90% 10-K · filed 2024-02-21 |
| 2022-12-31 | 6.90% 10-K · filed 2023-02-22 |
| 2021-12-31 | 6.00% 10-K · filed 2022-02-25 |
| 2020-12-31 | 7.00% 10-K · filed 2021-02-24 |
| 2019-12-31 | 7.60% 10-K · filed 2020-03-02 |
| 2019-09-30 | 7.50% 10-Q · filed 2019-11-06 |
| 2019-06-30 | 7.60% 10-Q · filed 2019-08-08 |
| 2019-03-31 | 7.60% 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |